Our innovation to Reconnect
A Natural Health Product
NeuroAiD™II is a natural health product which combines nine herbal extracts in the form of capsules. Available in over 35 countries worldwide, NeuroAiD™II supports the recovery of patients with neurological conditions.
NeuroAiD™II has been awarded Gold accreditation by independent non-profit Empowered By Evidence (EBE). The EBE accreditation affirms the robust clinical evidence behind NeuroAiD™II, as well as the rigour of its formulation and its consistent, batch-to-batch quality.
Patients with neurological conditions are encouraged to consult their treating physicians before considering NeuroAiD™II.
Supported by pre-clinical studies and clinical trials
R&D on NeuroAiD is very active. Over 90 scientific papers have been published since 2009 including pharmacological studies assessing the multiple properties of the product and the translation of its potential into clinical efficacy through randomised clinical trials.
This extensive research gives a strong international recognition to NeuroAiD. In addition to post-stroke recovery, recent data has shown promising results to address conditions such as cognitive decline, traumatic brain injuries and spinal cord injuries with NeuroAiD. The research is still ongoing to develop demonstrating the potential of the formulation but also by identifying the most active ingredients.
with multimodal mechanism of action
Its multi-ingredient composition gives NeuroAiD a multimodal mechanism of action enhancing the natural brain self-repair process by stimulating
- =Neuroplasticity
- =Neurogenesis
- =Angiogenesis
- =Modulation of Neuroinflammation
These properties give the possibility to repair the damaged areas to regain cognitive and functional capabilities
available in over 30 countries
Since its launch in Singapore in 2010, NeuroAiD™II has rapidly gained acceptance as an innovative natural treatment for post-stroke recovery. It is approved and marketed in many countries in South-East Asia, the Middle-East, Africa, Europe and CIS countries. Our ambition is to widen the availability of NeuroAiD™II in the years ahead.
The approved label of NeuroAiD™II varies from country to country, depending on local regulations, and so does the category of product in which NeuroAiDTMII is approved. As such, the information made available to the public varies from country to country.
As an Illustration:
Asia
- In Singapore, NeuroAiD™II is classified as a Chinese Proprietary Medicine to support neurological, motor and cognitive functions resulting in a better quality of life.
- In Vietnam, NeuroAiD™II is classified as a Traditional Medicine:
- Management of stroke or thrombotic diseases, and blood clots. Increase recovery for stroke patients (recovery of motor function, sensation, consciousness, perception, language); reduce spasticity paralysis symptoms.
- Support recovery of motor function, sensation, consciousness, perception, and language after trauma and surgery (owing to the effect of NeuroAiD™II on protecting and strengthening neurons in the area of brain injury, especially in the penumbra*).
*Penumbra: perfused brain tissue at a level within the thresholds of functional impairment and morphological integrity, which has the capacity to recover if perfusion is improved. - In traditional medicine treatment: Treat complications of apoplexy, blood stagnation (hemostasis), lack of coherence causing hemiplegia, difficult and sluggish speech, deviated eye and mouth, and unconscious mind.
- In Thailand, NeuroAiD™II is classified as a Developed Herbal Drug to support neurological, motor, and cognitive functions.
Europe
- In Bulgaria, NeuroAiD™II is classified as a Food Supplement to support neurological, motor and cognitive functions resulting in a better quality of life.
Middle East and Africa
- In Iraq, NeuroAiD™II is classified as a Herbal Medicine to support neurological functions, helping patients achieve a better recovery after an ischemic stroke onset. NeuroAiD™II is particularly effective in supporting motor recovery and spasticity reduction.
- In South Africa, NeuroAiD™II is classified as a Complementary Medicine to support neurological, motor, and cognitive functions.
CIS
- In Azerbaijan, NeuroAiD™II is classified as a Biologically Active Food Supplement to support neurological, motor, and cognitive functions, resulting in a better quality of life.
NeuroAiD™II is usually recommended by neurologists, neurosurgeons, and rehabilitation physicians. For more information on NeuroAiD™II’s label and status in your country, contact us at [email protected]
*This section presents the various research initiative conducted and being conducted on NeuroAiD and as such discussed the results of scientific research and clinical research conducted on NeuroAiD in cerebrovascular diseases. This information is intended to present the activities of the company and our commitment to develop product to help patients and families reconnect with their lives. It is intended for many different audiences such as investors, research partners, commercial partners, candidates… If your interest in NeuroAiD is for your own use or a family member, we recommend you seek guidance from a medical professional who will guide you in interpreting the data presented here.
